Back to results
US 12,590,159 B2Granted
Compositions targeting epidermal growth factor receptor and methods for making and using the same
AssigneeAmunix Pharmaceuticals, Inc.
InventorsViktoriya Dubrovskaya, Eric Johansen, Sina Khorsand, Lucas Liu, Volker Schellenberger, Milton To, Tracy Young, André Frenzel, Philipp Kuhn
Life of this patent
Estimating the term…
Abstract
The disclosure describes antibody binding domains for cluster of differentiation 3 T cell receptor (CD3), antibody binding domains for epidermal growth factor receptor (EGFR), cleavable linker sequences, and protease-activatable bispecific fusion proteins such as protease-activatable T cell engagers, as well as uses and methods of treatment.
Claims8
A polypeptide comprising the amino acid sequence of SEQ ID NO:1000.
Dependencies are inferred from the claim text.